C1 ESTERASE INHIBITOR (C1 INHIBITOR)CLINICAL UTILITY:Measuring the functional effect of the C1 esterase inhibitor protein is important in the diagnosis of Hereditary Angioedema (HAE),
a disease in which the protein is either decreased, absent, or inactive. In normal individuals, the protein blocks the enzymatic activities
of the C1 esterases, C1r and C1s, inhibiting complement activation.
The diagnosis of angioedema with depressed C1 esterase inhibitor (C1 inhibitor) should be suspected in patients with severe or
recurrent angioedema, especially when the angioedema involves the oropharynx and leads to airway obstruction, or involves the
abdominal wall and leads to abdominal pain or intestinal obstruction. The condition can be confirmed in the laboratory by finding
depressed levels of C1 esterase inhibitor. In HAE, the C1 inhibitor protein level (measured antigenically) is less than normal in 85% of
cases. In about 15% of patients, the protein level is normal but the protein is dysfunctional. Measurement of both C1 esterase inhibitor
protein level and functional activity is useful.
METHOD DESCRIPTION:The functional assay is performed by radial immunodiffusion (RID) inhibition, assaying the C1r level in the patient’s serum before
and after C1 is activated by model immune complexes. If C1 esterase inhibitor is present in sufficient quantity, C1r will be blocked, and
will not form a precipitin ring with the antibody in the gel. If C1 esterase inhibitor is insufficient, C1r will diffuse into the gel and form a
precipitin ring as it complexes with the antibody.
REFERENCE RANGE:Functional assay: > 68% of normal function.
SPECIMEN REQUIREMENTS:Functional assay: 1.0 ml serum (freeze within two hours and send on dry ice.)
|
© 2007
University of Washington. All rights reserved.
Notice of Privacy Practices | Copyright and Disclaimer